Allergy Emergency Action Plans

This article is part of our Food Allergies resource center, covering all aspects of food allergies diagnosis, treatment, and management.

What an Emergency Action Plan Is

An allergy emergency action plan is a written medical document that describes what to do — and in what sequence — when an allergic reaction occurs. It is specific to one person: their allergens, their prescribed medications, their emergency contacts, and the symptoms that indicate when each treatment step is appropriate. It is not a general guide to allergy; it is an individualized directive intended to be executed by people who may have no medical training but are present when a reaction occurs. The plan must be completed by a qualified healthcare provider and reviewed with a clinician at least annually. This page is distinct from the immediate emergency response covered in the food allergy emergency guide.

Who Should Have One

Anyone with a diagnosed allergy that carries a meaningful risk of anaphylaxis should have a written emergency action plan. This includes people with confirmed food allergies, insect venom allergies, drug allergies, and exercise-induced anaphylaxis who have experienced or are considered at risk for a severe systemic reaction. Children attending school or childcare should have an action plan on file with their school nurse and primary caregivers. Adults with severe allergies benefit from a plan shared with close contacts at home and at work. The plan is most useful to the non-medical people — family members, teachers, colleagues — who may be first to respond.

What an Action Plan Contains

A well-constructed allergy emergency action plan typically includes: the patient's name, photo, date of birth, and known allergens; a symptom checklist organized by mild versus severe presentation; specific medications authorized by the clinician for each scenario; clear instructions for epinephrine use including the device name and dose; instructions for when to call emergency services; the location where medications are stored; and names and phone numbers of primary caregiver, backup emergency contact, and prescribing physician. The action plan should not contain vague instructions. It should specify exactly which symptoms trigger which response and leave no room for ambiguity — a person witnessing a severe reaction for the first time should be able to read it and know exactly what to do.

Mild vs. Severe Symptoms and the Epinephrine Decision

One of the most important functions of an action plan is helping caregivers distinguish mild from potentially severe reactions. Mild symptoms may include isolated hives, itching, or mild nasal congestion without other systemic signs. Severe symptoms — indicating anaphylaxis — include any throat tightening, difficulty breathing or swallowing, hoarseness, a significant drop in blood pressure, loss of consciousness, pale or bluish skin, severe or sudden vomiting, or a combination of systems being affected simultaneously.

The plan should make the epinephrine decision explicit. A common instruction format directs the caregiver to give epinephrine immediately for severe or suspected severe symptoms. What must be universally clear is that antihistamines should not replace epinephrine when anaphylaxis is suspected — they are not fast-acting enough to address the life-threatening components of a severe reaction. The specific symptom thresholds and timing for epinephrine use must come from the individual's clinician, not from general guidelines alone.

Epinephrine: First-Line Response

Epinephrine is the only medication that effectively treats anaphylaxis. It works rapidly to constrict blood vessels, open airways, and reverse the systemic inflammatory response. Auto-injectors are designed to be used by non-medical personnel in emergencies and contain a single prescribed dose. The action plan should specify the device by name and describe where it is injected — typically the outer thigh, through clothing if necessary. Caregivers who have not practiced with an epinephrine device should use a training device — one that contains no needle or medication — so the motion is familiar before an emergency occurs.

After epinephrine is given, emergency services must be called even if symptoms appear to improve. Epinephrine is short-acting, and symptoms can return — a biphasic reaction — hours later. The person should be evaluated in an emergency department regardless of apparent recovery. The plan should state this explicitly so caregivers do not decide to wait and see after an initial improvement.

Second Dose Planning and Calling Emergency Services

Most guidelines recommend carrying at least two epinephrine auto-injectors because a second dose may be needed if symptoms do not improve, if symptoms return, or if emergency services are delayed. Emergency services should be called at the same time as or immediately after the first epinephrine dose — not after evaluating whether the first dose worked. Emergency services can provide additional treatment, transport to an emergency facility, and monitoring that caregivers cannot provide independently.

Multiple Copies and Storage Locations

An emergency action plan filed in a single location provides limited protection when a reaction occurs elsewhere. Copies of the current plan should be maintained wherever the person regularly spends time: the school nurse's office and classroom; the workplace; in the person's bag or wallet; and at the homes of regular caregivers. All copies must be the current signed version; outdated plans should be removed and replaced when updates are made. Medications referenced in the plan must be stored in accessible, known locations — retrievable within seconds, not minutes. For school-specific planning, see the school allergy safety guide.

Training Caregivers and Updating the Plan

Having a written plan is necessary but not sufficient. People who will execute the plan — family members, teachers, coaches, coworkers — need to read and understand it before a reaction occurs. A brief walkthrough including demonstration with a training epinephrine device substantially increases the likelihood of fast, correct response under stress. Regular staff training in schools and workplaces reduces barriers to appropriate action.

Action plans must stay current. Common issues include plans signed several years ago that no longer match current medications, updated prescriptions not reflected in the school's file, and emergency contact information that has not been refreshed. At minimum, review the plan at a clinical visit annually and update whenever any component changes. Common planning mistakes to avoid: creating a plan without clinician involvement; including vague symptom descriptions; omitting the specific epinephrine device name and instructions; not specifying when to call emergency services; not distributing copies to all relevant settings; and not scheduling annual reviews.